Navelbine

Links shared publicly online about this topic

Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial : The Lancet

thelancet.com — “Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial. By - Prof Robert Pirker MD, Jose R Pereira MD, Aleksandra Szczesna...View full resource at thelancet.com

  • View Related
  • Share

Most Recently Shared on May 4, 2009 at 9:56 pm By:

JackWestMD H. Jack West, MD Internist, Health Executive, Oncologist, Physician, and Doctor

Published report from the FLEX trial of cis/navelbine +/- erbitux (cetuximab) for adv NSCLC: http://tinyurl.com/FLEXLancet

3 years ago...

Oncology Medical News about Amenorrhea Epirubicin Breast Neoplasms

mdlinx.com — “Incidence of chemotherapy-induced amenorrhea associated with epirubicin, docetaxel and navelbine in younger breast cancer patientsView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on June 15, 2010 at 11:23 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Incidence of chemotherapy-induced amenorrhea associated with epirubicin, docetaxel and navelbine in young... http://bit.ly/8XJ1rj #oncology

2 years ago...

Oncology Article | Breast Neoplasms

mdlinx.com — “A phase II randomized study comparing navelbine and capecitabine (Navcap) followed either by Navcap or by weekly docetaxel in the first-line treatment of HER-2/neu negative metastatic breast cancerView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on January 4, 2011 at 12:03 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

A phase II randomized study comparing navelbine and capecitabine (Navcap) followed either by Navcap or... http://bit.ly/hydiRI #oncology

1 year ago...

Medical News: EBCC: New Standard Suggested for Metastatic Breast Cancer - in Meeting Coverage, EBCC from MedPage Today

medpagetoday.com — “BARCELONA " Patients with HER2-positive metastatic breast cancer lived just as long, but with significantly less toxicity, when treated with vinorelbine (Navelbine) and trastuzumab (Herceptin) than wiView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on March 29, 2010 at 12:41 am By:

FightCancer FightCancer Health News

EBCC: Study Suggests New Standard for Metastatic Breast Cancer (CME/CE) http://bit.ly/d9AZXr

2 years ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

  • JackWestMD

    H. Jack West, MD

    Seattle-based medical oncologist, Founder & President of cancer education non-profit Global Resource for Advancing Cancer Education (GRACE)

    View Profile

  • MDLinx

    Sandeep Pulim MD

    Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry

    View Profile

  • MDLinx

    Sandeep Pulim MD

    Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390